Indications and collaborations, page-5

Some great posts here.  Diabetes also a risk for heart disease & stroke.  Really looking forward to results of Xanadu trial early next year.  I thought it was so good they accepted extra patients onto the trial with so much interest internationally.  

With constant data collection during trials, I’m sure they would have some idea already as to success in AD.  We did have a beautiful article with some anecdotal evidence 

from a trial participant in Australia & his wife. You hope this is the norm & if the drug is working, trial participants get to stay on it on compassionate grounds, well after that washout period anyway.  Clinical trials can be a bit cruel in that respect.  But necessary for data.  GLTA for 2019 & wishing you all a Happy, healthy & Prosperous New Year.